Sun Pharma's profit falls on Organon deal charge; specialty drug sales remain strong

India's Sun Pharmaceutical Industries reported a drop in second-quarter profit on Friday, as ​a one-time charge largely tied to its planned acquisition of Organon weighed, though ‌demand for specialty medicines remained strong.